Price T Rowe Associates Inc 23and Me Holding Co. Transaction History

Price T Rowe Associates Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.71 - $0.97 $12,065 - $16,484	16,994 Added 27.09%	79,719 $73,000
Q3 2023 Nov 14, 2023	BUY	$0.96 - $2.01 $11,086 - $23,211	11,548 Added 22.56%	62,725 $62,000
Q2 2023 Aug 14, 2023	BUY	$1.59 - $2.29 $4,998 - $7,199	3,144 Added 6.55%	51,177 $90,000
Q1 2023 May 15, 2023	SELL	$2.05 - $2.87 $25,770 - $36,078	-12,571 Reduced 20.74%	48,033 $110,000
Q4 2022 Feb 14, 2023	SELL	$2.06 - $3.47 $33,139 - $55,821	-16,087 Reduced 20.98%	60,604 $131,000
Q3 2022 Nov 14, 2022	BUY	$2.6 - $5.12 $63,138 - $124,334	24,284 Added 46.34%	76,691 $220,000
Q2 2022 Aug 15, 2022	BUY	$2.19 - $3.98 $69,657 - $126,591	31,807 Added 154.4%	52,407 $130,000
Q4 2021 Feb 14, 2022	BUY	$6.55 - $13.25 $134,930 - $272,950	20,600 New	20,600 $137,000

116

82.5M

404K

292K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $795M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.